SOX4: A pivotal transcriptional hub and potential therapeutic target in hepatocellular carcinoma progression.
Clinically, SOX4 upregulation is tightly associated with advanced tumor stage and unfavorable survival, representing a promising tissue-based candidate biomarker for HCC diagnosis and prognosis, however, its clinical translation is hindered by cohort heterogeneity, insufficient prospective validation, unclear post-tran...